EN

News Room

Apr. 27, 2025

CE MDR-Certified enScope™ Digital Flexible Video Urology Endoscope System Now Available from EziSurg Medical

Shanghai, China – EziSurg Medical Co., Ltd., a leading innovator in minimally invasive surgical (MIS) solutions, proudly announces that its newly developed enScope™ Digital Flexible Video Urology Endoscope System (enScope™ Digital Flexible Cysto-Nephroscope, enScope™ Digital Flexibile Ureteroscope, Desktop and Portable Video Image Processor ) has been certified under the European Union Medical Device Regulation (EU MDR) 2017/745. This regulatory milestone marks a strategic expansion into the field of urology and reinforces the company’s commitment to delivering safe, high-performance, and user-friendly endoscopic devices to clinicians across Europe.


Product Portfolio


With CE MDR certification in place, ESM is now launching two advanced urology endoscopes and Two Video image processors.


enScope™ Ureteroscope

EziSurg Medical enScope™ Ureteroscope

  • 275° up/down tip bending angle to cope with stones at complex angles

  • 7.5Fr uniform diameter throughout the insertion tube for smooth navigation and sufficient backwater space


enScope™ Cysto-Nephroscope

EziSurg Medical enScope™ Cysto-Nephroscope

  • High-definition image quality for clearer visualization

  • 210° tip bending angle to support precise inspection and treatment


Video Image Processors

Two endoscopes

  • Two endoscopes connected at the same time


These devices reflect EziSurg Medical’s user-centric innovation philosophy, integrating advanced engineering with clinical practicality to meet the evolving needs of urologists worldwide.


According to iData Research, the global urological endoscope market is projected to grow significantly, reaching USD 3.4 billion in the coming years[1]. In Europe, the urological device market is also expanding steadily[2]. This trend underscores the relevance and timeliness of EziSurg Medical’s entry into the European urology market with the enScope™ product line.


“Having achieved CE MDR certification, we are proud to introduce innovative urology solutions that comply with the stringent regulatory standards of the European market,” said Henry Nie, Founder and Chairman of EziSurg Medical. “This achievement not only strengthens our presence in the European market, but also represents a significant step forward in the global commercialization of the enScope™ Urology portfolio.”


Looking ahead, EziSurg Medical remains steadfast in its mission—to advance MIS technologies, alleviate patient suffering, and improve quality of life—by combining cutting-edge engineering with clinical practicality to meet the evolving needs of urological care.


References:

[1] Urological Endoscope Market Size, Share & Trend Analysis | Global | 2025-2031 | MedCore | Includes: Cytoscope Market, Ureteroscope Market, and 2 more. (2024, December 20). IData Research.

https://idataresearch.com/product/global-urological-endoscope-market/

[2] Urology Market Size, Share & Trends Analysis | Europe | 2025-2031 | MedSuite | Includes: Urinary Catheters, Urinary Incontinence Slings, and 7 more. (2024, September 27). IData Research.

https://idataresearch.com/product/urological-device-market-europe/


ABOUT EZISURG


EziSurg Medical Co., Ltd. (referred to as “EziSurg Medical”) was established in November 2011 in Shanghai, specializes in the R&D and industrialization of premium minimally invasive surgery (MIS) solutions worldwide. 


With a highly competitive product portfolio including surgical stapling series, surgical energy platform and surgical endoscopy platform, EziSurg is committed to improving surgical outcomes in general, bariatric, thoracic, colorectal, gynecological, and other minimally invasive procedures. Our vision is to become a preferred global provider of reliable, accessible, and affordable comprehensive MIS solutions. To date, EziSurg Medical’s self-developed products have achieved cumulative global sales of nearly 5 million units and have been used in over 1,400 hospitals across China, of which Grade A tertiary hospitals account for more than 40%. In the international front, EziSurg Medical has received entry approvals of more than 80 countries and regions worldwide.


For more information, please visit: 

https://en.ezisurg.com/


Headquarters (China)

Address

No. 399 Miaoqiao Road, Pudong New District, Shanghai 201315, P.R. China

Phone

+86 400-090-6176

Fax

+86 21-5067-6156

Website

https://en.ezisurg.com

U.S. Subsidiary

Address

Suite 403, 6136 Frisco Square Blvd., Frisco, Texas 75034, USA

Phone

+1 469-252-2118

Or Leave Us a Message, We Will Get Back to You Asap!

Copyright © Ezisurg Medical Co., Ltd. All Rights Reserved. | Sitemap Privacy Policy Terms of Services | Powered by Reanod

WeChat